NERVGEN PHARMA CORP.(NGEN)— Stock Profile, AI Score & Financials

Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings.

NERVGEN PHARMA CORP. (NGEN) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. NGEN is not currently included in 13F Pro's AI-ranked quality universe — this company has no xbrl financial filings on file with sec edgar. common for adrs, recent ipos, otc-listed names, and foreign filers that haven't filed 20-f yet. Top institutional holders of NGEN by reported 13-F value include Empery Asset Management, Rock Springs Capital Management, DAFNA Capital Management, based on the most recent SEC filings. NGEN trades on the Nasdaq exchange and files with the SEC under CIK 1751912. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate NGEN daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for NERVGEN PHARMA CORP. directly from SEC EDGAR.